Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
24,183
Sort by:
Global Pharma Grade Zein Market Growth 2026-2032
US$ 3,660.00
The global Pharma Grade Zein market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Pharma G...
April 2026
84 pages
Global GLP-1 Drug Peptide API Market Growth 2026-2032
US$ 3,660.00
The global GLP-1 Drug Peptide API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. GLP-1 (Glucagon-Like Peptide...
April 2026
95 pages
Global Triptans Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Triptans market size is expected to reach $ 1663 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). Triptans are a class of selective 5-HT1B/1D...
April 2026
195 pages
Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share & Trends Analysis Report By Action of Mechanism (Complement Inhibitors, Supportive Care, Others), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The Japan paroxysmal nocturnal hemoglobinuria treatment market size was valued at USD 279.95 million in 2025 and is projected to reach USD 455.53 million by 2033, growing at a CAGR of 5.88% from 2026...
April 2026
150 pages
Neuropathic Pain Market Size, Share & Trends Analysis Report By Drug Class, (Anticonvulsants, Antidepressants), By Indication (Diabetic Peripheral Neuropathy, Postherpetic Neuralgia), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global neuropathic pain market size was estimated at USD 8.53 billion in 2025 and is projected to reach USD 15.23 billion by 2033, growing at a CAGR of 7.58% from 2026 to 2033. The neuropathic pai...
April 2026
150 pages
Global Crohn’s Disease Market - 2025-2033
US$ 2,999.00
The Global Crohn’s Disease Market was valued at USD 14.6 billion in 2025 and is anticipated to reach USD 21.8 billion by 2033, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insigh...
April 2026
220 pages
Myasthenia Gravis Therapeutics Market - 2025-2033
US$ 2,999.00
The Myasthenia Gravis Therapeutics Market was valued at USD 1.64 billion in 2025 and is anticipated to reach USD 3.48 billion by 2033, at a CAGR of 0.096 from 2026 to 2032. The report delivers in-dept...
April 2026
243 pages
